Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Molecular Transfer was a biotechnology company specializing in the development and commercialization of advanced transfection technologies and cell culture reagents. The company focused on providing high-efficiency delivery systems for nucleic acids into mammalian cells, which are critical for drug discovery, protein production, and functional genomics. Its proprietary technologies were designed to optimize the performance of cell-based assays and bioproduction workflows. Molecular Transfer was eventually acquired by Life Technologies (now part of Thermo Fisher Scientific), where its intellectual property and product lines were integrated into a broader portfolio of life science research tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Molecular Transfer.